Another COVID-19 vaccine candidate NVX-CoV2373 (Novavax), based on the full-length of S protein, could trigger a robust immune response in human beings like the dimeric RBD-based protein subunit vaccine (ZF2001) [9,31]. Here, PROS1 is linked to COVID-19.